Curis Inc CRIS
$0.83
▼ -5.62%
($-0.05)
🧊 52W Low
⬇️ Below Yest. Low
🎈 Low Float
🎢 High Beta
Open
$0.90
Prev Close
$0.88
Day Range
$0.81 – $0.96
52W Range
$0.86 – $34.80
Market Cap
$1.73M
Beta
3.58
EPS (TTM)
$-14.33
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2000-08-01 |
| Shares Out. | 1,950,000 |
| Website | curis.com/ ↗ |
| Phone | 13026587581 |
| Employees | 24 |
| Revenue | $0 |
| Gross Profit | $0 |
| Net Income | -$8.6M |
| Free Cash Flow | -$30.6M |
| Total Assets | $19.0M |
| Total Liabilities | $14.3M |
| Equity | $4.7M |
About Curis Inc
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Curis Inc is a publicly traded company under the ticker symbol CRIS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-09-01)